Work

Abstract 3787: The safety of PARP inhibitors combined with immune checkpoint inhibitors versus immune checkpoint inhibitor monotherapy: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3787

Authors: Mus'ab Theeb Mustafa, Aws Khalid Abushanab, Ahmad Yousef Alazzam, Mahmoud Taysir Mousa, Ahmad Sa'ed, Noor N. Al-Bzour, Osama Wadah Rammaha, Zaher Mutaz Ashour, Hamza Muneer Alakhras, Yihea Mohammad Al-Mashaqbah, Ahmad Sami Othman, Nour Maher Mustafa, Renad Fawwaz Al Banawi, Anwaar Saeed

Institutions: Hashemite University, Jordan University Hospital, Jordan University of Science and Technology, University of Pittsburgh

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148690139

Cites:

Cited by:

Related to: